Sector consensus MBX Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-10 pm EDT			5-day change	1st Jan Change
31.00 ^USD	-5.66%		-6.03%	-1.71%

Mar. 16	Mbx Biosciences Insider Bought Shares Worth $525,663, According to a Recent SEC Filing	MT
Mar. 12	MBX Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
MBX BIOSCIENCES, INC.	62.55	+90.34%	11
LONZA GROUP AG	675.78	+33.5%	23
BEONE MEDICINES AG	408.2	+30.24%	26
CELLTRION, INC.	254,500	+26.3%	24
IQVIA HOLDINGS INC.	232.25	+37.44%	20
REVOLUTION MEDICINES, INC.	133.7	+38.95%	20
ASCENDIS PHARMA A/S	250.86	+21.41%	16
MEDPACE HOLDINGS, INC.	500.08	-0.28%	12
EUROFINS SCIENTIFIC SE	71.85	+12.27%	14
IONIS PHARMACEUTICALS, INC.	97.31	+27.32%	22
ABIVAX	121.82	+15.47%	7
PRAXIS PRECISION MEDICINES, INC.	617.62	+92.86%	16
BIO-TECHNE CORPORATION	73.64	+32.51%	11
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	197.64	+12.58%	14
QIAGEN N.V.	55.46	+35.24%	14
ICON PUBLIC LIMITED COMPANY	131.92	+23.64%	13
TEMPUS AI, INC.	75.43	+70.81%	14
PHARMARON BEIJING CO., LTD.	37.34	+22.23%	12
Average	14,346.86	+34.60%	16
Weighted average by Cap.	26,976.3	+30.83%	19